Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVF

NCT04414761 is registered in ClinicalTrials.gov with ShangHai Ji Ai Genetics & IVF Institute as lead sponsor.

NCT NCT04414761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVF
Lead sponsor
ShangHai Ji Ai Genetics & IVF Institute
Phase
Phase 3
Overall status
Completed
Start date
June 4, 2020
Completion date
October 10, 2022
Enrollment
784 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gnrh antagonist, ivf, ppos